Effect of teduglutide, a glucagon-like peptide-2 analog, in eosinophilic enterocolitis: a case report

被引:0
|
作者
Ogawa, Shoko [1 ]
Konishi, Ken-ichiro [1 ]
Tanaka, Kiyoshi [2 ]
Takayasu, Hajime [1 ]
Uematsu, Yoshimasa [1 ]
Ito, Takashi [3 ]
Takahashi, Hiroyuki [4 ]
Kumamoto, Yusuke [1 ]
机构
[1] Kitasato Univ, Sch Med, Dept Gen Pediat & Hepatobiliary Pancreat Surg, Sagamihara, Kanagawa, Japan
[2] Kitasato Univ, Sch Med, Res & Dev Ctr New Med Frontiers, Dept Adv Med,Div Pediat Surg, Sagamihara, Kanagawa, Japan
[3] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa, Japan
[4] Kitasato Univ, Sch Allied Hlth Sci, Dept Pathol, Sagamihara, Kanagawa, Japan
来源
FRONTIERS IN PEDIATRICS | 2024年 / 12卷
关键词
glucagon-like peptide-2 analog; immune effect; short bowel syndrome; eosinophilic gastrointestinal diseases; teduglutide; COWS MILK ALLERGY; ANTIINFLAMMATORY ACTIONS; INFLAMMATION; PATHWAYS; BARRIER;
D O I
10.3389/fped.2024.1457824
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We successfully treated a 4-year-old girl with short bowel syndrome and eosinophilic enterocolitis with teduglutide, a glucagon-like peptide-2 analog. Her eosinophilic enterocolitis was cured without relapse, and we were able to increase enteral nutrition. We found that teduglutide had an anti-inflammatory effect in this patient with eosinophilic gastrointestinal disease associated with short bowel syndrome. This report is the first to describe use of teduglutide in the treatment of eosinophilic gastrointestinal disease.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] The "cryptic" mechanism of action of glucagon-like peptide-2
    Rowland, Katherine J.
    Brubaker, Patricia L.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2011, 301 (01): : G1 - G8
  • [22] Structural determinants for activity of glucagon-like peptide-2
    DaCambra, MP
    Yusta, B
    Sumner-Smith, M
    Crivici, A
    Drucker, DJ
    Brubaker, PL
    BIOCHEMISTRY, 2000, 39 (30) : 8888 - 8894
  • [23] Intestinal rehabilitation using semisynthetic glucagon-like peptide-2 analogue. First experience with teduglutide in Uruguay
    Moreira, Eduardo
    Silva, Lourdes
    Olano, Estela
    Solar, Hector
    REVISTA MEDICA DEL URUGUAY, 2021, 37 (03):
  • [24] Expression, purification and molecular dynamics simulation of extracellular domain of glucagon-like peptide-2 receptor linked to teduglutide
    Kandjani, Omid Jamshidi
    Alizadeh, Ali Akbar
    Moosavi-Movahedi, Ali Akbar
    Kheradmand, Sahar Sadr
    Dastmalchi, Siavoush
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 184 : 812 - 820
  • [25] Teduglutide, a Human Recombinant Analog of Glucagon-Like Peptide-2 (GLP-2), Increases Plasma Citrulline Levels in Patients With Short Bowel Syndrome
    Messing, Bernard
    Joly, Francisca
    Schwartz, Lauren K.
    Iyer, Kishore R.
    Chu, Henry
    Youssef, Nader
    GASTROENTEROLOGY, 2012, 142 (05) : S369 - S369
  • [26] Colonic Dysplasia Is Increased By Glucagon-Like Peptide-2 in Azoxymethane-Treated Mice and Is Decreased By Antagonism of the Glucagon-Like Peptide-2 Receptor
    Iakoubov, Roman
    Lauffer, Lina
    Trivedi, Shivangi
    Sie, Karen Kai Yi
    Kim, Young-In J.
    Brubaker, Patricia L.
    GASTROENTEROLOGY, 2009, 136 (05) : A754 - A754
  • [27] Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1
    Nagell, CF
    Wettergren, A
    Pedersen, JF
    Mortensen, D
    Holst, JJ
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (04) : 353 - 358
  • [28] Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
    Ammann, Markus
    Santol, Jonas
    Pereyra, David
    Kalchbrenner, Tamara
    Wuerger, Tanja
    Laengle, Johannes
    Smoot, Rory L.
    Hulla, Wolfgang
    Laengle, Friedrich
    Starlinger, Patrick
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [29] Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2
    Brubaker, PL
    Anini, Y
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 81 (11) : 1005 - 1012
  • [30] Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
    Markus Ammann
    Jonas Santol
    David Pereyra
    Tamara Kalchbrenner
    Tanja Wuerger
    Johannes Laengle
    Rory L. Smoot
    Wolfgang Hulla
    Friedrich Laengle
    Patrick Starlinger
    Scientific Reports, 13